Minerva Neurosciences (NERV) Assets (2013 - 2026)

Minerva Neurosciences (NERV) has 14 years of Assets data on file, last reported at $94.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 186.68% year-over-year to $94.0 million; the trailing twelve-month figure through Mar 2026 stood at $94.0 million (up 186.68% YoY), and the FY2025 full-year result was $98.0 million, up 163.76% from the prior year.
• Assets for Q1 2026 stood at $94.0 million, down from $98.0 million in the prior quarter.
• Across five years, Assets topped out at $98.0 million in Q4 2025 and bottomed at $28.1 million in Q3 2025.
• The 5-year median for Assets is $55.1 million (2022), against an average of $55.8 million.
• The widest annual swing landed in 2022, when Assets tumbled 38.75%; it then soared 186.68% in 2026.
• A 5-year view of Assets shows it stood at $55.1 million in 2022, then gained by 3.29% to $56.9 million in 2023, then tumbled by 34.72% to $37.1 million in 2024, then surged by 163.76% to $98.0 million in 2025, then dropped by 4.02% to $94.0 million in 2026.
• The last three Assets figures came in at $94.0 million (Q1 2026), $98.0 million (Q4 2025), and $28.1 million (Q3 2025), per Business Quant data.

Peer Comparison